Window of Opportunity Study Targeting the Inflammatory Milieu
- Conditions
- Stage IB Breast CancerStage II Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IA Breast CancerStage IIIA Breast CancerStage IV Breast Cancer
- Interventions
- Dietary Supplement: Omega-3 fatty acid
- First Posted Date
- 2013-06-19
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 42
- Registration Number
- NCT01881048
- Locations
- 🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States
Improving Function, Participation and Function After Acute Hospitalization in Older Adults
- Conditions
- Frail Older Adults
- Interventions
- Behavioral: Progressive Multi-Component InterventionBehavioral: Usual Care
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 30
- Registration Number
- NCT01872637
- Locations
- 🇺🇸
Arcadia University, Glenside, Pennsylvania, United States
🇺🇸University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States
Validation of Lower Body Negative Pressure (LBNP) Model of Human Hemorrhage in Trauma Patients
- Conditions
- Physical Trauma
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2019-10-08
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 50
- Registration Number
- NCT01871909
- Locations
- 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸Denver Health Medical Center, Denver, Colorado, United States
🇺🇸San Antonio Military Medical Center, San Antonio, Texas, United States
Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy
- Conditions
- Hematologic Neoplasms
- First Posted Date
- 2013-06-05
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 40
- Registration Number
- NCT01869218
- Locations
- 🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States
Phase II Trial for Large ER-Negative Breast Cancers
- Conditions
- Malignant Neoplasm of Female Breast
- Interventions
- First Posted Date
- 2013-06-05
- Last Posted Date
- 2019-09-24
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 72
- Registration Number
- NCT01869192
- Locations
- 🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States
Emergency Department (ED) Drug Interaction in Emergency Department Patients
- Conditions
- Drug Interactions
- Interventions
- First Posted Date
- 2013-05-22
- Last Posted Date
- 2016-05-05
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 502
- Registration Number
- NCT01859715
- Locations
- 🇺🇸
University of Colorado, Aurora, Colorado, United States
Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis
- Conditions
- Cystic Fibrosis
- Interventions
- Drug: AquADEKs-2Dietary Supplement: control multivitamin
- First Posted Date
- 2013-05-21
- Last Posted Date
- 2017-07-14
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 73
- Registration Number
- NCT01859390
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
🇺🇸Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
🇺🇸Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States
Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- First Posted Date
- 2013-05-15
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 61
- Registration Number
- NCT01853553
- Locations
- 🇺🇸
UColorado, Aurora, Colorado, United States
Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects
- Conditions
- Schizophrenia
- Interventions
- Device: AVL-3288Drug: Placebo
- First Posted Date
- 2013-05-10
- Last Posted Date
- 2016-12-30
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 12
- Registration Number
- NCT01851603
- Locations
- 🇺🇸
U of Colorado Denver, Aurora, Colorado, United States
Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2018-06-04
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 7
- Registration Number
- NCT01845792
- Locations
- 🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States